Final report of the Lyme disease review panel of the Infectious Diseases Society of America.
Abstract
In April 2008, the Infectious Diseases Society of America (IDSA) entered into an agreement
with Connecticut Attorney General Richard Blumenthal to voluntarily undertake a special
review of its 2006 Lyme disease guidelines. This agreement ended the Attorney General's
investigation into the process by which the guidelines were developed. The IDSA agreed
to convene an independent panel to conduct a one-time review of the guidelines. The
Review Panel members, vetted by an ombudsman for potential conflicts of interest,
reviewed the entirety of the 2006 guidelines, with particular attention to the recommendations
devoted to post-Lyme disease syndromes. After multiple meetings, a public hearing,
and extensive review of research and other information, the Review Panel concluded
that the recommendations contained in the 2006 guidelines were medically and scientifically
justified on the basis of all of the available evidence and that no changes to the
guidelines were necessary.
Type
Journal articleSubject
Anti-Bacterial AgentsAntitrust Laws
Conflict of Interest
Connecticut
Drug Administration Schedule
Health Policy
Humans
Lyme Disease
Practice Guidelines as Topic
Societies, Medical
United States
Permalink
https://hdl.handle.net/10161/4154Published Version (Please cite this version)
10.1086/654809Publication Info
Lantos, Paul M; Charini, William A; Medoff, Gerald; Moro, Manuel H; Mushatt, David
M; Parsonnet, Jeffrey; ... Baker, Carol J (2010). Final report of the Lyme disease review panel of the Infectious Diseases Society of
America. Clin Infect Dis, 51(1). pp. 1-5. 10.1086/654809. Retrieved from https://hdl.handle.net/10161/4154.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Paul Michael Lantos
Professor of Medicine
I am interested in the spatial epidemiology of infectious diseases. My research utilizes
geographic information systems (GIS) and geostatistical analyses to understand the
spatial and spatiotemporal distribution of diseases, and their relationship with environmental
and demographic factors. I currently have active studies evaluating the spatial distribution
of numerous domestic and international infectious diseases, including SARS-CoV-2 (COVID-19),
cytomegalovirus, influenza, and Lyme disease. A

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info